BF
IONS icon

BOK Financial’s Ionis Pharmaceuticals IONS Stock Holding History

BOK Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18
Closed -$543 – 1239
2025
Q1 		$543 Hold
18
– – ﹤0.01% 1217
2024
Q4 		$602 Buy
+18
New +$673 ﹤0.01% 1232
2024
Q2 		– Sell
-7
Closed -$308 – 1218
2024
Q1 		$308 Buy
+7
New +$334 ﹤0.01% 1148
2023
Q4 		– Sell
-26,974
Closed -$1.19M – 1284
2023
Q3 		$1.19M Sell
26,974
-31,776
-54% -$1.31M 0.03% 409
2023
Q2 		$2.41M Sell
58,750
-1,511
-3% -$58.1K 0.05% 307
2023
Q1 		$2.15M Buy
+60,261
New +$2.26M 0.05% 339
2021
Q1 		$526K Buy
11,710
+4,025
+52% +$224K 0.01% 679
2020
Q4 		$435K Sell
7,685
-4,521
-37% -$225K 0.01% 695
2020
Q3 		$579K Sell
12,206
-1,813
-13% -$101K 0.01% 587
2020
Q2 		$827K Sell
14,019
-5,699
-29% -$317K 0.02% 502
2020
Q1 		$932K Sell
19,718
-2,781
-12% -$155K 0.03% 430
2019
Q4 		$1.36M Sell
22,499
-2,864
-11% -$171K 0.03% 438
2019
Q3 		$1.52M Buy
+25,363
New +$1.65M 0.04% 407
2015
Q3 		– Sell
-4,714
Closed -$271K – 863
2015
Q2 		$271K Sell
4,714
-78
-2% -$4.96K 0.01% 723
2015
Q1 		$305K Buy
+4,792
New +$325K 0.01% 672

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BOK Financial's IONS Position: Q2 2025 in Review

BOK Financial sold out of Ionis Pharmaceuticals (IONS) in Q2 2025, closing a stake of 18 shares — an estimated $543 sold.

BOK Financial first reported a position in IONS in Q1 2015 and held it in 15 quarters. The position peaked at $2.41M in Q2 2023. 362 funds tracked by Wall St. Rank hold IONS as of Q2 2025.

  • BOK Financial reported no remaining Ionis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • BOK Financial sold 18 Ionis Pharmaceuticals shares in Q2 2025, an estimated $543.
  • BOK Financial first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 15 quarters.
  • BOK Financial's Ionis Pharmaceuticals position peaked at $2.41M in Q2 2023.
  • 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2025.

Based on BOK Financial's 13F filing for Q2 2025, filed 12 Aug 2025.